Trimurthi Drugs & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 15, 2012, has considered and approved the allotment of 13,50,000 convertible warrants to the non promoters on preferential basis.Source : BSE
Read all announcements in Trimurthi Drugs
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!